Summary The California Institute for Regenerative Medicine (CIRM) has invested approximately $70 million in programs targeting various orthopedic indications, including osteoporosis, bone fracture healing, vertebral compression fractures, and several others. The present article serves to outline the current state of CIRM’s more advanced programs, comparing and contrasting them with the current standard of care and several other novel approaches under development. - See more at: http://www.stemcellsportal.com/content/2015-0202#sthash.Zek9KMW5.XyVokFbX.dpuf
CITATION STYLE
Littman, N., & Abo, A. (2015). Proceedings: Using Stem Cell Therapies to Reestablish Osteogenic Capability for Bone Regeneration. Stem Cells Translational Medicine, 4(11), 1247–1250. https://doi.org/10.5966/sctm.2015-0202
Mendeley helps you to discover research relevant for your work.